Pimm – Partial immortalization

A Biotech Geek (micro)Blogger’s adventures through science, technology and the web…

  • email me

    [attilacsordas][at][gmail.com]
  • Attila on Twitter

    • Red Mars before sleep &after JavaScript:dropping windmills=>spin=>heat in coils=>release to atmosphere, winds slowing down=>dust storms down 13 hours ago
    • Hard to believe, learn in what sense? See/trial & error? RT @GreatDismal I learn more watching people use new tech than using it myself 15 hours ago
    • nephews (11,13) just learned how to run, modify & debug the 'Hello World' JavaScript on the iPhone w/ Notes, variables & functions next ;) 20 hours ago
    • Family party this afternoon: preparing w/little JavaScript snippets on the iPhone for my nephews so they can run scripts on their iPod touch 1 day ago
    • Safari is losing http requests to Chrome/Firefox on my laptop due to the lack of an omnibox capability 1 day ago
  • Recent Comments

    GB on Visualize 23andMe haplogroup d…
    MaryHollmy on Google Health, IBM: real-time,…
    colon hydrotherapy l… on Why the Dyna-Vision G1 Android…
    revathi on Human mitochondrial DNA vs. nu…
    Erik Cole on Michael Rose, evolutionary SEN…
    drugrehabusa on Stem Cell Therapy Market, US, …
    Letago on Can you tell a good article fr…
    Online Offers on Life extension people are happ…
    เสื้อผ้า on How to read PDF files on iPhon…
    atsoft on Add stem cells and eat the lab…
  • licence

    Creative Commons License
  • c

  •  

    July 2008
    M T W T F S S
    « Jun   Aug »
     123456
    78910111213
    14151617181920
    21222324252627
    28293031  

Archive for July 28th, 2008

The marketing problem of life extension technologies

Posted by attilachordash on July 28, 2008

If “Science has a really serious marketing problem” as Larry Page observed, then life extension technologies face even bigger marketing problems. I am definitely not a marketing expert but realized the problem early on when thinking about the lag-phase period of a robust life extension technology.  So I made a short email interview with Dave Gobel, the marketing and business mind/strategist behind the Methuselah Foundation (official title: Chief Executive Officer) following our meeting and chat at the SENS3 conference in Cambridge, UK, 2007.

1. What is the biggest marketing problem of any future (or present) healthy life extension technology?

The biggest marketing problem today is the time it takes for a beneficial effect to present itself. For instance, a product such as resveratrol may take months to present beneficial results, or it may never show up clinically. People who are scientifically sophisticated can appreciate the value of reduced circulating fats or glucose, but to the typical individual, there are much sexier things to spend money on that give immediate gratification and clear utility. The proof of this is illustrated by a counter example – how ridiculously easy it would be to sell a product that biologically reversed grey hair. The effect might be seen gradually but incontrovertably by all and in the mirror directly.

It seems to me that the best way to proceed from a business standpoint therefore is from the outside in. Create legitimate products that improve a person’s visual image and therefore social standing and they will flock for the result. Try to engineer those products to have globally beneficial effects, and marketing becomes easy.

So, for the present, the problem is delayed, and difficult to pinpoint results in exchange for expensive pills/treatments and never ending taking of pills. What about the future? The problem of marketing will evaporate as tissue engineering provides an immediate benefit by eliminating hip, knee and similar pains while restoring or even improving base functionality. When biologically matched teeth can be implanted and grown anew in gums, marketing will be easy.

2. How to market life extension for different generations (teenagers, college students, young adults, mature adults, grandpas and grandmas) and what are the main differences here? Read the rest of this entry »

Posted in Aubrey de Grey, Cambridge, Mprize, SENS, SENS3, UK, biotechnology, blogterview, business 2.0, life extension, longevity, partial immortalization | 3 Comments »